Hemophilia Services Consortium Inc
Hemophilia Services Consortium Inc consistently matches revenue with expenses, showing significant asset growth but also high liabilities.
EIN: 133875950 · New York, NY · NTEE: E21Z · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $21.2M |
| Total Expenses | $21.2M |
| Program Spending | 90% |
| CEO/Top Officer Pay | $20 |
| Net Assets | $124K |
| Transparency Score | 85/100 |
Is Hemophilia Services Consortium Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Hemophilia Services Consortium Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Hemophilia Services Consortium Inc
Hemophilia Services Consortium Inc (EIN: 133875950) is a nonprofit organization based in New York, NY, classified under NTEE code E21Z. The organization reported total revenue of $21.2M and total assets of $7.5M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Hemophilia Services Consortium Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Hemophilia Services Consortium Inc is a large nonprofit that has been operating for 29 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 2.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $21.2M |
| Total Expenses | $21.2M |
| Surplus / Deficit | +$0 |
| Total Assets | $7.7M |
| Total Liabilities | $7.6M |
| Net Assets | $124K |
| Operating Margin | 0.0% |
| Debt-to-Asset Ratio | 98.4% |
| Months of Reserves | 4.4 months |
Financial Health Grade: B
In 2023, Hemophilia Services Consortium Inc reported a surplus of $0 with revenue exceeding expenses, holds 4.4 months of operating reserves (adequate), has a debt-to-asset ratio of 98.4% (high leverage).
Financial Trends
Over 13 years of filings (2011–2023), Hemophilia Services Consortium Inc's revenue has grown at a compound annual growth rate (CAGR) of 2.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +3.2% | +3.2% | +31.5% |
| 2022 | +14.5% | +14.5% | +30.1% |
| 2021 | -1.5% | -1.5% | +9.8% |
| 2020 | +9.9% | +9.9% | +55.2% |
| 2019 | -3.2% | -3.2% | -6.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1997 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Hemophilia Services Consortium Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 5%
- programs: 90%
- fundraising: 5%
According to IRS 990 filings, Hemophilia Services Consortium Inc allocates its expenses as follows: admin: 5%, programs: 90%, fundraising: 5%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $0, with revenue exceeding expenses.
- Debt-to-asset ratio: 98.4%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that no officers received compensation from the organization, which is highly unusual for an organization with over $20 million in annual revenue and suggests a volunteer-led or externally compensated leadership structure.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Hemophilia Services Consortium Inc's IRS 990 filings:
- High proportion of liabilities relative to assets, consistently over 90% in recent years, which could indicate significant operational debt or specific financial structures that need clarification.
- 0% officer compensation for an organization with over $20 million in annual revenue is highly unusual and could suggest an alternative compensation structure or reliance on external support for leadership, which impacts transparency regarding leadership costs.
Strengths
The following positive indicators were identified for Hemophilia Services Consortium Inc:
- Consistent financial stability with revenues closely matching expenses across all reported periods, indicating sound financial management.
- Significant asset growth from $3,015,582 in 2014 to $7,715,828 in 2023, demonstrating an increasing resource base.
- Strong commitment to mission, as evidenced by the reported 0% officer compensation, suggesting funds are directed towards programs rather than executive salaries.
- Long and consistent history of IRS 990 filings (13 filings), indicating good regulatory compliance and transparency over time.
Frequently Asked Questions about Hemophilia Services Consortium Inc
Is Hemophilia Services Consortium Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Hemophilia Services Consortium Inc (EIN: 133875950) some concerns. Mission Score: 85/100. 2 red flags identified, 4 strengths noted.
How does Hemophilia Services Consortium Inc spend its money?
Hemophilia Services Consortium Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Hemophilia Services Consortium Inc tax-deductible?
Hemophilia Services Consortium Inc is registered as a tax-exempt nonprofit (EIN: 133875950). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Hemophilia Services Consortium Inc CEO make?
Hemophilia Services Consortium Inc's highest-compensated officer earns $20 annually. The organization reported $21.2M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Hemophilia Services Consortium Inc's spending goes to programs?
Hemophilia Services Consortium Inc directs 90% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Hemophilia Services Consortium Inc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Hemophilia Services Consortium Inc is above average for NTEE category E21Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Hemophilia Services Consortium Inc located?
Hemophilia Services Consortium Inc is headquartered in New York, New York and files with the IRS under EIN 133875950. It is classified under NTEE code E21Z.
How many years of IRS 990 filings does Hemophilia Services Consortium Inc have?
Hemophilia Services Consortium Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $21.2M in total revenue.
What is the nature of the high liabilities reported by Hemophilia Services Consortium Inc?
The filings consistently show liabilities that are very close to the total assets (e.g., $7,591,417 in liabilities vs. $7,715,828 in assets in 2023). This could be due to specific program-related payables, grants received in advance, or other operational debts. A deeper dive into the balance sheet details would be needed to understand the exact nature and implications of these liabilities.
How does Hemophilia Services Consortium Inc manage its executive leadership without reported officer compensation?
The consistent 0% officer compensation across all filings suggests that executive leadership may be entirely volunteer-based, compensated by a related entity, or that the organization's structure does not involve direct compensation for its officers as defined by the IRS 990. This is a significant factor for an organization of its size and warrants further inquiry into its operational model.
What is the specific breakdown of program, administrative, and fundraising expenses?
While the provided data shows total revenue and expenses, a detailed breakdown of how these expenses are allocated among programs, administration, and fundraising is not available. This information is crucial for a complete assessment of spending efficiency and program impact.
Filing History
IRS 990 filing history for Hemophilia Services Consortium Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Hemophilia Services Consortium Inc's revenue has grown by 38.2%, moving from $15.4M to $21.2M. Total assets increased by 195.7% over the same period, from $2.6M to $7.7M. Total functional expenses rose by 38.2%, from $15.4M to $21.2M. In its most recent filing year (2023), Hemophilia Services Consortium Inc reported a surplus of $0, with revenue exceeding expenses. The organization holds $7.6M in liabilities against $7.7M in assets (debt-to-asset ratio: 98.4%), resulting in net assets of $124K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $21.2M | $21.2M | $7.7M | $7.6M | — | View 990 |
| 2022 | $20.6M | $20.6M | $5.9M | $5.7M | — | View 990 |
| 2021 | $18.0M | $18.0M | $4.5M | $4.4M | — | View 990 |
| 2020 | $18.2M | $18.2M | $4.1M | $4.0M | — | View 990 |
| 2019 | $16.6M | $16.6M | $2.6M | $2.5M | — | View 990 |
| 2018 | $17.1M | $17.1M | $2.8M | $2.7M | — | View 990 |
| 2017 | $18.4M | $18.4M | $4.8M | $4.6M | — | View 990 |
| 2016 | $17.0M | $16.9M | $4.1M | $4.0M | — | View 990 |
| 2015 | $16.2M | $16.2M | $3.0M | $2.9M | — | View 990 |
| 2014 | $17.5M | $17.5M | $3.0M | $2.9M | — | View 990 |
| 2013 | $16.6M | $16.6M | $2.5M | $2.4M | — | View 990 |
| 2012 | $16.4M | $16.4M | $4.5M | $4.5M | — | View 990 |
| 2011 | $15.4M | $15.4M | $2.6M | $2.5M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $21.2M, expenses of $21.2M, and assets of $7.7M (revenue +3.2% year-over-year).
- 2022: Revenue of $20.6M, expenses of $20.6M, and assets of $5.9M (revenue +14.5% year-over-year).
- 2021: Revenue of $18.0M, expenses of $18.0M, and assets of $4.5M (revenue -1.5% year-over-year).
- 2020: Revenue of $18.2M, expenses of $18.2M, and assets of $4.1M (revenue +9.9% year-over-year).
- 2019: Revenue of $16.6M, expenses of $16.6M, and assets of $2.6M (revenue -3.2% year-over-year).
- 2018: Revenue of $17.1M, expenses of $17.1M, and assets of $2.8M (revenue -6.7% year-over-year).
- 2017: Revenue of $18.4M, expenses of $18.4M, and assets of $4.8M (revenue +8.3% year-over-year).
- 2016: Revenue of $17.0M, expenses of $16.9M, and assets of $4.1M (revenue +4.8% year-over-year).
- 2015: Revenue of $16.2M, expenses of $16.2M, and assets of $3.0M (revenue -7.5% year-over-year).
- 2014: Revenue of $17.5M, expenses of $17.5M, and assets of $3.0M (revenue +5.1% year-over-year).
- 2013: Revenue of $16.6M, expenses of $16.6M, and assets of $2.5M (revenue +1.4% year-over-year).
- 2012: Revenue of $16.4M, expenses of $16.4M, and assets of $4.5M (revenue +6.8% year-over-year).
- 2011: Revenue of $15.4M, expenses of $15.4M, and assets of $2.6M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Hemophilia Services Consortium Inc:
Data Sources and Methodology
This transparency report for Hemophilia Services Consortium Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.